Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 7:08 PM
Ignite Modification Date: 2025-12-25 @ 4:42 PM
NCT ID: NCT02008357
Term: Squamous cell carcinoma
Organ System: Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA 25.0
Notes: None
Study: NCT02008357
Study Brief: Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 39 32 572 View
EG001 53 29 591 View
EG002 22 19 383 View
EG003 19 9 401 View